UNSPSC 51373466: Guaifenesin/hydrocodone/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373466 Guaifenesin/hydrocodone/phenylephrine is a Commodity code covering specific pharmaceutical products procured by state and local health authorities and cooperative purchasing alliances. The actual work being solicited under this code spans generic multi-source pharmaceuticals and over-the-counter products distributed through state and local government facilities, with vendors supplying directly to authorized wholesalers or delivering to community health buildings. Issuing bodies include state departments of administration (Minnesota), county health departments (Seminole County, Florida), and multistate cooperative purchasing alliances that coordinate procurement across multiple participating jurisdictions and states.

Recent activity shows two representative opportunities: the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products to be distributed across participating state and local facilities, including Oregon, with contract awards effective July 1, 2026; and Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2026) to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. The geographic spread includes Florida and Minnesota as anchor states, with the MMCAP cooperative extending procurement coordination to Oregon and other participating jurisdictions. Both solicitations emphasize cGMP compliance, FDA requirements, E-Verify and drug-free workplace certification, and insurance requirements including workers' compensation and commercial general liability coverage.